Regardless, the results present here demonstrate a signaling pathway encompassing GRα, REG1CP, FANCJ and REG3A that promotes CRC cell proliferation and tumorigenesis and propose that REG1CP may constitute a molecular target for CRC treatment. This evidence concerns the gene REG3A and colorectal carcinoma.